Literature DB >> 20430953

Roles for growth factors in cancer progression.

Esther Witsch1, Michael Sela, Yosef Yarden.   

Abstract

Under physiological conditions, cells receive fate-determining signals from their tissue surroundings, primarily in the form of polypeptide growth factors. Integration of these extracellular signals underlies tissue homeostasis. Although departure from homeostasis and tumor initiation are instigated by oncogenic mutations rather than by growth factors, the latter are the major regulators of all subsequent steps of tumor progression, namely clonal expansion, invasion across tissue barriers, angiogenesis, and colonization of distant niches. Here, we discuss the relevant growth factor families, their roles in tumor biology, as well as the respective downstream signaling pathways. Importantly, cancer-associated activating mutations that impinge on these pathways often relieve, in part, the reliance of tumors on growth factors. On the other hand, growth factors are frequently involved in evolvement of resistance to therapeutic regimens, which extends the roles for polypeptide factors to very late phases of tumor progression and offers opportunities for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430953      PMCID: PMC3062054          DOI: 10.1152/physiol.00045.2009

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  111 in total

1.  Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF.

Authors:  A B Roberts; M A Anzano; L C Lamb; J M Smith; C A Frolik; H Marquardt; G J Todaro; M B Sporn
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

2.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

Authors:  Alejandra Bruna; Rachel S Darken; Federico Rojo; Alberto Ocaña; Silvia Peñuelas; Alexandra Arias; Raquel Paris; Avelina Tortosa; Jaume Mora; Jose Baselga; Joan Seoane
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

3.  Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.

Authors:  Christian Fischer; Bart Jonckx; Massimiliano Mazzone; Serena Zacchigna; Sonja Loges; Lucia Pattarini; Emmanuel Chorianopoulos; Laurens Liesenborghs; Marta Koch; Maria De Mol; Monica Autiero; Sabine Wyns; Stephane Plaisance; Lieve Moons; Nico van Rooijen; Mauro Giacca; Jean-Marie Stassen; Mieke Dewerchin; Desire Collen; Peter Carmeliet
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

4.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

Authors:  C Sell; G Dumenil; C Deveaud; M Miura; D Coppola; T DeAngelis; R Rubin; A Efstratiadis; R Baserga
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

5.  Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

Authors:  S M Gorsch; V A Memoli; T A Stukel; L I Gold; B A Arrick
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

6.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

7.  Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors.

Authors:  Paul Haluska; Heather M Shaw; Gretchen N Batzel; Donghua Yin; Julian R Molina; L Rhoda Molife; Timothy A Yap; M Luisa Roberts; Amarnath Sharma; Antonio Gualberto; Alex A Adjei; Johann S de Bono
Journal:  Clin Cancer Res       Date:  2007-10-01       Impact factor: 12.531

Review 8.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

9.  Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata.

Authors:  E Y Lee; G Parry; M J Bissell
Journal:  J Cell Biol       Date:  1984-01       Impact factor: 10.539

10.  Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.

Authors:  Samy Lamouille; Rik Derynck
Journal:  J Cell Biol       Date:  2007-07-23       Impact factor: 10.539

View more
  154 in total

1.  Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.

Authors:  François Gaascht; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2015-11-17       Impact factor: 5.523

2.  The effects of self-assembling peptide RADA16 hydrogel on malignant phenotype of human hepatocellular carcinoma cell.

Authors:  Hong Song; Yun-Zhu Han; Guo-Hui Cai; Fu-Shan Tang; Ze-Hong Yang; Di-Shu Ao; An Zhou
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  A review of spatial computational models for multi-cellular systems, with regard to intestinal crypts and colorectal cancer development.

Authors:  Giovanni De Matteis; Alex Graudenzi; Marco Antoniotti
Journal:  J Math Biol       Date:  2012-05-08       Impact factor: 2.259

Review 4.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

5.  Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Xu Han; Sun Yan; Zhang Weijie; Wang Feng; Wang Liuxing; Li Mengquan; Fan Qingxia
Journal:  Cancer Gene Ther       Date:  2014-01-24       Impact factor: 5.987

6.  A novel technique for in situ uniaxial tests of self-assembled soft biomaterials.

Authors:  Mohamed Elhebeary; Md Abul Bashar Emon; Onur Aydin; M Taher A Saif
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

7.  Age-Dependent Cellular and Behavioral Deficits Induced by Molecularly Targeted Drugs Are Reversible.

Authors:  Joseph Scafidi; Jonathan Ritter; Brooke M Talbot; Jorge Edwards; Li-Jin Chew; Vittorio Gallo
Journal:  Cancer Res       Date:  2018-03-20       Impact factor: 12.701

Review 8.  Revisiting the hallmarks of cancer.

Authors:  Yousef Ahmed Fouad; Carmen Aanei
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.

Authors:  S Carvalho; M Lindzen; M Lauriola; N Shirazi; S Sinha; A Abdul-Hai; K Levanon; J Korach; I Barshack; Y Cohen; A Onn; G Mills; Y Yarden
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts: a transcriptomic study.

Authors:  Mahesh M Kumar; Sravanthi Davuluri; Sridhar Poojar; Geetashree Mukherjee; Akhilesh Kumar Bajpai; Uttam Dungarmal Bafna; Uma K Devi; Pramod P R Kallur; Acharya K Kshitish; R S Jayshree
Journal:  Tumour Biol       Date:  2015-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.